Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › CAPR Leadership & Pay · Jun 8, 2026
Capricor Therapeutics, Inc. held its Annual Meeting of stockholders on June 4, 2026, and announced the election of… CAPR Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. held its Annual Meeting of stockholders on June 4, 2026, and announced the election of eight directors to the Company's Board of Directors. The meeting also included votes on the ratification of its independent accounting firm, the approval ofing of executive officer compensation, and the eration of an amendment to the Certificate of Incorporation regarding officer exculpation.
More from Capricor Therapeutics, Inc. Capricor Therapeutics announced that the FDA extended the PDUFA target action date for its Biologics License… Aug 24, 2026 Capricor Therapeutics reported second quarter 2026 financial results on August 13, 2026 Aug 13, 2026 On July 29, 2026, the FDA's Cellular, Tissue and Gene Therapies Advisory Committee voted that available evidence did… Jul 30, 2026 Capricor Therapeutics announced the publication of final one-year results from its Phase 3 HOPE-3 trial for Deramiocel… Jul 29, 2026 Capricor Therapeutics, Inc. entered into a lease agreement for approximately 171,000 rentable square feet in San… Jul 14, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
